CONMED CORPORATION (CNMD) Total liabilities 2016–2025
CONMED CORPORATION (CNMD) total liabilities at each fiscal year-end, per SEC filings.
$1.3BFY2025 · since FY2016: $748.4M → $1.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.3B | -3.8% |
| FY2024 | $1.3B | -8.3% |
| FY2023 | $1.5B | -5.6% |
| FY2022 | $1.6B | +58.3% |
| FY2021 | $980.6M | -6.0% |
| FY2020 | $1.0B | -2.1% |
| FY2019 | $1.1B | +50.6% |
| FY2018 | $706.9M | -2.7% |
| FY2017 | $726.5M | -2.9% |
| FY2016 | $748.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CNMD financial trends
CNMD RevenueCNMD Net incomeCNMD Net marginCNMD Gross profitCNMD Gross marginCNMD Operating incomeCNMD Operating marginCNMD Operating cash flowCNMD Free cash flowCNMD Capital expendituresCNMD Return on equityCNMD Stock buybacksCNMD Dividends paidCNMD Total assetsCNMD Shareholders’ equityCNMD overview →